Author(s):
Shreyash Manapure, Akash Pachare, Rushikesh Shirbhate, Bhushan Manapure
Email(s):
smanapure345@gmail.com
DOI:
10.52711/2321-5836.2024.00012 
Address:
Shreyash Manapure*, Akash Pachare, Rushikesh Shirbhate, Bhushan Manapure
Department of Pharmacology, Dr. Rajendra Gode Institute of Pharmacy, Amravati – 444606.
*Corresponding Author
Published In:
Volume - 16,
Issue - 2,
Year - 2024
ABSTRACT:
There are major public health problems associated with the misuse of prescription drug abuse problem and the illegal sale of medications without valid prescriptions. This paper analyzes theproblems, focusing on how they affect people's health, healthcare systems, and the pharmaceutical sector. The study focuses on the Amravati District in Maharashtra, India, where concerns regarding public health interventions and regulatory frameworks are raised by a rise in prescription drug usage. The study looks at the prevalence, underlying causes, and effects of misuse in order to pinpoint trends, contributing elements, and the size of illegal sales. The interaction of socioeconomic factors, cultural influences, and healthcare accessibility is explored to provide insight into prescription drug misuse in the local environment.The global context explores how prescription drug abuse is recognized by the World Health Organization, with a focus on the risks associated with addiction, overdose, and negative health outcomes.The influence of COVID-19 on the pharmaceutical sector is discussed in the research, with an emphasis on the rising usage of telemedicine and the greater reliance on online platforms.
Cite this article:
Shreyash Manapure, Akash Pachare, Rushikesh Shirbhate, Bhushan Manapure. Misuse of Prescription Drugs and Illicit Sales without Prescription in Amravati District. Research Journal of Pharmacology and Pharmacodynamics. 2024;16(2):65-2. doi: 10.52711/2321-5836.2024.00012
Cite(Electronic):
Shreyash Manapure, Akash Pachare, Rushikesh Shirbhate, Bhushan Manapure. Misuse of Prescription Drugs and Illicit Sales without Prescription in Amravati District. Research Journal of Pharmacology and Pharmacodynamics. 2024;16(2):65-2. doi: 10.52711/2321-5836.2024.00012 Available on: https://rjppd.org/AbstractView.aspx?PID=2024-16-2-1
REFERENCES:
1. Jayawardhani V, Kamtane RA, Kulkarni AK. Pharmaco-epidemiological study of self-medication pattern in Hyderabad. Research Journal of Pharmacy and Technology. 2012; 5(8): 1114-7.
2. Wal P, Wal A, Srivastava R, Rastogi P, Rai AK. Antibiotic therapy in pediatric patients. Research Journal of Pharmacy and Technology. 2010; 3(1): 118-20.
3. Sangale D, Jadhav RA, Darade BD, Sanap AN. Rational Use of Drugs in Acute Pharyngitis. Research Journal of Pharmacy and Technology. 2013; 6(4): 370-4.
4. Awale P, Sonawane D, Dhananjay S, Mhatre D, Misal C, Shaikh Z, Gulbhile S, Khambalkar S, Naik A. Study of Drug Utilization 90% in Health Centre. Research Journal of Pharmacy and Technology. 2013; 6(8): 899-901.
5. Bhamare AB, Bhamankar KH, Khairnar AS. Drug Utilization 90% of Urinary Tract Infections Drugs–A Simple Method for Assessing the Quality of Drug Prescribing. Research Journal of Pharmacy and Technology. 2011; 4(8):1328-30.
6. Rout SK, Dutta S, Sengupta M, Das S. The Management Aspect of Duodenal Ulcer with Special Reference to Diet and Pharmacotherapy. Research Journal of Pharmacy and Technology. 2010; 3(3): 721-6.
7. Pavithra D, Praveen D, Aanandhi MV. A Comprehensive Review on Complications of Intravenous Drug Abuse. Research Journal of Pharmacy and Technology. 2017; 10(5): 1523-7.
8. Mahadik PS, Senthilkumar GP, Powar AS, Devprakash D, Mani TT, Gavali SA. Chemical and biological properties of benzodiazepines-An overview. Research Journal of Pharmacy and Technology. 2012; 5(2): 181-9.
9. Hosen SM, Saha D, Khanam UH, Barua S, Rashid M, Khan MA, Emran TB, Dey TK, Afser AS. Evaluation of Drug-Drug Interaction in a Patient Drugs Profile with Multiple Complicacy and Patient Management. Research Journal of Pharmacy and Technology. 2012; 5(6): 813-6.
10. Anis MS, Azmi MH. Pharmaceutical digital marketing of non-prescription drugs: a systematic scoping review. Research Journal of Pharmacy and Technology. 2022; 15(2): 941-6.
11. Malviya V, Pande S. Design and Characterization of pH Dependent Phase Transition System of Almotriptan Malate for Nasal Drug Delivery System by Employing Factorial Design. Ind. J. Pharm. Edu. Res. 2024; 58(1): 76-90.
12. Bergman U, Dahl-Puustinen ML. Use of prescription forgeries in a drug abuse surveillance network. European Journal of Clinical Pharmacology. 1989 Nov; 36: 621-3.
13. Wilford BB, Finch J, Czechowicz DJ, Warren D. An overview of prescription drug misuse and abuse: Defining the problem and seeking solutions. Journal of Law, Medicine & Ethics. 1994; 22(3): 197-203.
14. Inciardi JA, Surratt HL, Lugo Y, Cicero TJ. The diversion of prescription opioid analgesics. InLaw Enforcement Executive Forum. 2007; 7(7): 127.
15. National Ctr on Addiction and Substance Abuse at Columbia University (CASA), United States of America, Beau Dietl & Associates (BDA), and United States of America. You've Got Drugs!: Prescription Drug Pushers on the Internet. 2004.
16. Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug and Alcohol Dependence. 2008 Jan 1; 92(1-3): 267-76.
17. McCabe SE, Teter CJ, Boyd CJ, Knight JR, Wechsler H. Nonmedical use of prescription opioids among US college students: Prevalence and correlates from a national survey. Addictive Behaviors. 2005 May 1; 30(4): 789-805.
18. Lessenger JE, Feinberg SD. Abuse of prescription and over-the-counter medications. The Journal of the American Board of Family Medicine. 2008 Jan 1; 21(1): 45-54.
19. Abuse S. Mental health services administration. Results from the. 2013 Jan 10; 2: 13.
20. Agarwal, D. S. P., and D. T. A. B. Chairman. Central Drugs Standard Control Organization. 2017.
21. Bandameedi R, Mohammed S, Soma H. A case study on National List of Essential Medicines (NLEM) in India and WHO EML 2015-overview. Pharm Regul Aff. 2016; 5(1).
22. Doraiswamy S, Abraham A, Mamtani R, Cheema S. Use of telehealth during the COVID-19 pandemic: scoping review. Journal of Medical Internet Research. 2020 Dec 1; 22(12): e24087.
23. Bashshur R, Doarn CR, Frenk JM, Kvedar JC, Woolliscroft JO. Telemedicine and the COVID-19 pandemic, lessons for the future. Telemedicine and e-Health. 2020 May 1; 26(5): 571-3.
24. Anis MS, Tan ML. Exploring OTC drug consumers’ perception towards online shopping and digital marketing through qualitative interviews: A sample from Malaysia. International Journal of Healthcare Management. 2023 Jan 5: 1-9.
25. Pawar KN, Gore RT, Palekar SR. A review on approval process and regulation of medical devices as per US FDA and CDSCO. International Journal of Drug Regulatory Affairs. 2023; 11(1): 61-70.
26. Thakker DB, Patel KG. Preventing Prescription Drug Misuse: A Regulatory Perspective in the United States, Europe, and India. International Journal of Drug Regulatory Affairs. 2021; 9(4): 46-52.
27. Doshi M, Parbat M, Paudyal V, Marriott J. Bridging the gap between academia and practice: novel organogram at the Pharmacy Council of India. Journal of Pharmaceutical Policy and Practice. 2022 Mar 20; 15(1): 22.
28. Saxena OP, Dubey G. National Medical Commission: New Trends In Medical Field. Research Ambition: An International Multidisciplinary e-Journal. 2022; 6(IV): 6-8